Detalhe da pesquisa
1.
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152053
2.
Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature.
Pediatr Blood Cancer
; 69(5): e29499, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939322
3.
Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children.
Transplant Cell Ther
; 29(6): 391.e1-391.e7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934995
4.
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.
J Exp Clin Cancer Res
; 42(1): 21, 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639636
5.
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.
Blood Adv
; 5(22): 4783-4793, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525182
6.
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia.
Blood Adv
; 7(2): 251-255, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500285